Hinazosin
Appearance
Nazivi | |
---|---|
Preferisani IUPAC naziv
6,7-Dimetoksi-2-[4-(prop-2-en-1-il)piperazin-1-il]hinazolin-4-amin | |
Identifikacija | |
3D model (Jmol)
|
|
ChemSpider | |
UNII | |
| |
Svojstva | |
C17H23N5O2 | |
Molarna masa | 329,40 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
Reference infokutije | |
Hinazosin je antihipertenzivni antagonist α1-adrenergičkog receptor.[3]
Reference
[uredi | uredi izvor]- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Martin, RA; Barsoum, NJ; Sturgess, JM; De La Iglesia, FA (1985). „Leukocyte and bone marrow effects of a thiomorpholine quinazosin antihypertensive agent”. Toxicology and Applied Pharmacology. 81 (1): 166—73. PMID 3840293. doi:10.1016/0041-008x(85)90131-0.